Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

December 31, 2011

Conditions
Rosacea
Interventions
DRUG

CD07805/47 gel

applied topically once daily

DRUG

Placebo

applied topically once daily

Trial Locations (15)

19034

Philadelphia Institute of Dermatology, Fort Washington

24501

The Education & Research Foundation, Inc., Lynchburg

27262

Dermatology Consulting Services, High Point

37922

The Skin Wellness Center, Knoxville

48038

Michigan Center for Skin Care Research, Clinton Township

72230

Dermatology Treatment & Research Center, Dallas

76011

Arlington Center for Dermatology, Arlington

78759

DermResearch, Inc., Austin

90045

Dermatology Research Associates, Los Angeles

94143

University of California, San Francisco, San Francisco

97223

Oregon Medical Research Center, Portland

08520

Windsor Dermatology, East Windsor

L3P 1A8

Lynderm Research Inc, Markham

N8W 5L7

Windsor Clinical Research Inc., Windsor

H2K 4L5

Innovaderm Research, Inc, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY